α<sub>1</sub>‐Antitrypsin Deficiency and the PiMS Phenotype

doi:10.1002/j.1536-4801.1989.tb09711.x

Mark F. Gourley, Glenn R. Gourley, Enid F. Gilbert, Gerard B. Odell

α₁‐Antitrypsin Deficiency and the PiMS Phenotype

Gastroenterology
Pediatrics, Perinatology and Child Health

We describe a premature infant with cholestatic liver disease and protease inhibitor MS phenotype. This infant demonstrated an abnormally low serum α1‐antitrypsin concentration. Liver histologic studies revealed diastase‐resistant, periodic acid‐Schiff‐positive globules inside hepatocytes. Immunoperoxidase staining for α1‐antitrypsin was positive. Electron microscopy showed amorphous material in the dilated lumina of the endoplasmic reticulum. These findings are characteristic of α1‐antitrypsin deficiency. We suggest that this usually nonpathologic phenotype resulted in cholestatic liver disease because of the cumulative effect of several cholestatic conditions.

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

Web-based, modern reference management
Collaborate and share with fellow researchers
Integration with Overleaf
Comprehensive BibTeX/BibLaTeX support
Save articles and websites directly from your browser
Search for new articles from a database of tens of millions of references

Try out CiteDrive

α₁‐Antitrypsin Deficiency and the PiMS Phenotype

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

More from our Archive

Development and Validation of a Pediatric Crohn's Disease Activity Index

The IMPACT Questionnaire: A Valid Measure of Health‐Related Quality of Life in Pediatric Inflammatory Bowel Disease

Guidelines for Evaluation and Treatment of Gastroesophageal Reflux in Infants and Children

Pancreatitis in Children

Fecal Calprotectin: Validation as a Noninvasive Measure of Bowel Inflammation in Childhood Inflammatory Bowel Disease

Recurrent Abdominal Pain: Symptom Subtypes Based on the Rome II Criteria for Pediatric Functional Gastrointestinal Disorders

Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease

Upper Gastrointestinal Mucosal Disease in Pediatric Crohn Disease and Ulcerative Colitis: A Blinded, Controlled Study

Growth Failure in Pediatric Inflammatory Bowel Disease

The Complexity of Feeding Problems in 700 Infants and Young Children Presenting to a Tertiary Care Institution

α1‐Antitrypsin Deficiency and the PiMS Phenotype

Need a simple solution for managing your BibTeX entries? Explore CiteDrive!

More from our Archive

Development and Validation of a Pediatric Crohn's Disease Activity Index

The IMPACT Questionnaire: A Valid Measure of Health‐Related Quality of Life in Pediatric Inflammatory Bowel Disease

Guidelines for Evaluation and Treatment of Gastroesophageal Reflux in Infants and Children

Pancreatitis in Children

Fecal Calprotectin: Validation as a Noninvasive Measure of Bowel Inflammation in Childhood Inflammatory Bowel Disease

Recurrent Abdominal Pain: Symptom Subtypes Based on the Rome II Criteria for Pediatric Functional Gastrointestinal Disorders

Fecal Calprotectin as a Measure of Disease Activity in Childhood Inflammatory Bowel Disease

Upper Gastrointestinal Mucosal Disease in Pediatric Crohn Disease and Ulcerative Colitis: A Blinded, Controlled Study

Growth Failure in Pediatric Inflammatory Bowel Disease

The Complexity of Feeding Problems in 700 Infants and Young Children Presenting to a Tertiary Care Institution

α₁‐Antitrypsin Deficiency and the PiMS Phenotype